The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Regulatory News (HAYD)

Share Price Information for Haydale (HAYD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.445
Bid: 0.43
Ask: 0.46
Change: -0.015 (-3.26%)
Spread: 0.03 (6.977%)
Open: 0.46
High: 0.46
Low: 0.445
Prev. Close: 0.46
HAYD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Post Period End Trading Update

19 Jul 2022 07:00

RNS Number : 8714S
Haydale Graphene Industries PLC
19 July 2022
 

This announcement contains inside information.

 

 

For immediate release

19 July 2022

 

Haydale Graphene Industries plc

 

('Haydale' or the 'Group')

Post period end trading update

Haydale, (AIM: HAYD), the global advanced materials group, announces a trading update for the year ended 30 June 2022 (the "Year" or "FY2022").

The Group now anticipates, subject to audit, announcing revenues for the Year ahead of prior expectations at approximately £2.90 million with gross profit of approximately £1.74 million and LBITDA marginally behind prior guidance at £3.35 million. Capital Expenditure in the Year was £1.00 million and Year end cash stood at £1.19 million.

As previously indicated, the commercial momentum from the second half of the Year is expected to accelerate into the new financial year with both an increased customer and product portfolio contributing to this. Against this increase, the annualised impact of the investment in sales, marketing, quality and production resource during FY2022 alongside the inflationary cost pressures we are seeing at our operating units will partly offset the expected uplift in revenue at the LBITDA level. We anticipate that the current year LBITDA will be smaller than FY2022 but not to the extent previously expected.

Notwithstanding this, with the significant increase that the HT1400 has delivered to the Group's functionalisation capacity combined with the investment made in human capital the Board remains confident that it has the fundamental building blocks in place to take advantage of the commercial traction it is seeing. The Board remain confident in the medium and longer term prospects for the Group.

 

For further information:

 

 

Haydale Graphene Industries plc

Keith Broadbent, CEO

Mark Chapman, CFO

Tel: +44 (0) 1269 842 946

 

www.haydale.com 

finnCap (Nominated Adviser & Broker)

Julian Blunt/Edward Whiley, Corporate FinanceAndrew Burdis, ECM

 

Tel: +44 (0) 20 7220 0500

 

Notes to Editors

 

Haydale is a global technologies group and service provider that facilitates the integration of graphene and other nanomaterials into the next generation of industrial materials and commercial technologies. With expertise in graphene, other nanomaterials and Silicon Carbide, Haydale is able to deliver improvements in electrical, thermal and mechanical properties, Haydale has been granted patents for its technologies in Europe, USA, Australia, Japan and China and operates from five sites in the UK, USA and East Asia. For more information please visit: www.haydale.com or Twitter: @haydalegraphene

 

Caution regarding forward looking statements

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

 

A number of factors could cause actual results to differ materially from the results discussed in the forward-looking statements including risks associated with vulnerability to general economic and business conditions, competition, environmental and other regulatory changes, actions by governmental authorities, the availability of capital markets, reliance on key personnel, uninsured and underinsured losses and other factors, many of which are beyond the control of the Company. Although any forward looking statements contained in this announcement are based upon what the Directors believe to be reasonable assumptions, the Company cannot assure investors that actual results will be consistent with such forward looking statements. Accordingly, readers are cautioned not to place undue reliance on forward looking statements. Subject to any continuing obligations under applicable law or any relevant AIM Rule requirements, in providing this information the Company does not undertake any obligation to publicly update or revise any of the forward looking statements or to advise of any change in events, conditions or circumstances on which any such statement is based.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTRPMATMTABBJT
Date   Source Headline
13th Jun 20189:00 amRNSPrice Monitoring Extension
13th Jun 20187:00 amRNSTrading Statement and Director Resignation
25th May 20187:00 amRNSHaydale Ceramics Technologies
16th Apr 20189:10 amRNSNotification of Major Holdings
1st Mar 20187:00 amRNSInterim Results
19th Feb 20187:00 amRNSSupply Agreement with Graphene Platform Corp
25th Jan 20187:00 amRNSTrading Update
18th Jan 20187:00 amRNSChange of Adviser
17th Jan 20187:00 amRNSCommercial Agreement with Talga Resources
18th Dec 20177:00 amRNSShare options and awards, LTIP and PDMR dealings
12th Dec 201711:25 amRNSResult of AGM
20th Nov 20177:00 amRNSNew Patent Application
20th Nov 20177:00 amRNSAnnual Report & Notice of AGM
1st Nov 20177:00 amRNSPDMR Dealings
31st Oct 20175:48 pmRNSNotification of Major Holdings
30th Oct 20177:00 amRNSGrant of US Patent
27th Oct 201710:45 amRNSResult of General Meeting, Issue of Equity and TVR
26th Oct 201710:06 amRNSResult of Conditional Offer
19th Oct 20171:20 pmRNSCREST Clarification
10th Oct 20174:21 pmRNSClose of Accelerated Bookbuild
10th Oct 20177:00 amRNSProposed Accelerated Bookbuild to raise £6 million
10th Oct 20177:00 amRNSFull Year Results
26th Sep 20177:00 amRNSEverpower places initial orders for Chinese market
11th Sep 20177:00 amRNSChange of Adviser
1st Sep 20177:00 amRNSNew Sales Contract
22nd Aug 20177:00 amRNSAdvanced Composites Proposed Collaboration
9th Aug 20177:00 amRNSLaunch of Taiwan operations
19th Jul 20177:00 amRNSTrading update
13th Jul 20177:00 amRNSAppointment of Chairman
29th Jun 20177:00 amRNSGrant of Options
20th Jun 20177:00 amRNSIssue of Equity and Total Voting Rights
24th May 201711:30 amRNSPDMR Dealing
15th May 20177:00 amRNSAcquisition of HTI Minority Interest
11th May 20177:00 amRNSMemorandum of Understanding with Nanospan India
9th May 20177:00 amRNSIssue of Equity and Total Voting Rights
28th Apr 20177:00 amRNSIssue of Shares
25th Apr 20177:00 amRNSPDMR Dealing
19th Apr 20177:00 amRNSPDMR Dealing
10th Apr 20177:00 amRNSIssue of Equity and Total Voting Rights
10th Apr 20177:00 amRNSIssue of Shares
31st Mar 20174:00 pmRNSIssue of Equity and Total Voting Rights
31st Mar 20177:00 amRNSIssue of Shares
27th Mar 20175:05 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
22nd Mar 20177:00 amRNSInterim Results
15th Mar 20177:00 amRNSFour-year supply agreement
7th Mar 20177:00 amRNSIssue of Shares
20th Feb 20177:00 amRNSIssue of Shares
3rd Feb 20177:01 amRNSProposed Strategic Investment
3rd Feb 20177:00 amRNSTrading update & Notice of results
16th Jan 201711:45 amRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.